Find a TenderAwarded
Published 15 Sept 2021, 13:10 BST

Official UK procurement notice

NHS Framework for the North of England, Branded Medicine

Official notice

Authority: The NHS Commissioning Board (operating under the name of NHS England) (NHS & healthcare)

Framework agreement5 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: UK
Framework ceiling (notional)£863,999,552total for 5 lots · framework ceiling, not attributable revenue
Submissions closed 20 Oct 2021awarded 7 Feb 2022
Lots 5see the lot list below
Framework period 2 yrsends 29 Feb 2024 · extension options published · starts 1 Mar 2022

What is being bought5 lots · detail below

Published requirement description

HS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)

CPV: Pharmaceutical products

How this framework works

From the published notice
Bids received
23 bids on the busiest of 5 lots · 27 suppliers appointed
Framework period
2 yrs from 1 Mar 2022

Lots and requirements (5)Procurement structure

5 lots · no lot values published
Lot #1CM/PHR/20/5600/01 - NHS Framework for the NOFE, Branded Medicines - Tranche BAwarded 2 yrs

CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months

Contract period: 1 Mar 2022 – 29 Feb 2024 (2 yrs)
Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsVariant bids: allowed
Lot #2CM/PHR/20/5600/02 - NHS Framework for the NOFE, Branded Medicines-Annual TrancheAwarded 1 yr

CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Contract period: 1 Mar 2022 – 28 Feb 2023 (1 yr)
Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.Variant bids: allowed
Lot #3CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofEAwarded 6 mo

CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months.

Contract period: 1 Mar 2022 – 31 Aug 2022 (6 mo)
Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 6 months.Variant bids: allowed
Lot #4CM/PHR/20/5600/04-NHS Framework for Insulin Aspart Biosimilar (Trurapi®), LondonAwarded 1 yr 6 mo

CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 18 months.

Contract period: 1 Mar 2022 – 31 Aug 2023 (1 yr 6 mo)
Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 18 months.Variant bids: allowed
Lot #5CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaEAwarded 1 yr

CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Contract period: 1 Mar 2022 – 28 Feb 2023 (1 yr)
Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.Variant bids: allowed

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “NHS Framework for the North of England, Branded Medicine” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
15 Sept 2021, 13:10 BST
Last source update
1 Mar 2022, 12:15 GMT
Award evaluation window
20 Oct 2021 – …
FTS notice number
2022/S 000-005550
Classification (CPV)
Pharmaceutical products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-02e103 Find a Tender
Contract terms
Electronic trading
e-invoicing allowed · electronic ordering · electronic payment
Performance terms

Selection criteria as stated in the procurement documents

Publisher note: RESPONDING TO THIS NOTICE;Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.ukCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select- review opportunity details and click "Register Interest"- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at [email protected] or by calling 0800 9956035 for technical assistance when completing responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide theircompany profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will stillbe on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.ukand select "Register" at the top of the page.Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via themessage function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.

How it was run

Official notice
Run through: Atamis (Health Family) · Who buys & how to bid on Atamis
Supplier login requiredLanguage: EN
Access & registration note: Free · one account PER buying organisation portal · password resets come "from Salesforce.com" (check spam)

Tender documents are also served through a separate tool: http://health.atamis.co.uk ↗

Appointment period ends
20 Oct 2021, 13:00 BST
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bid validity
90 days from the deadline
Bids opened
20 Oct 2021, 13:00 BST
Detailed submission instructions & authority contactsFrom official release

Timeline

20 Oct 2021 → 1 Mar 2022 · 4 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    20 Oct 2021, 13:00 BST
  2. Bids opened
    20 Oct 2021, 13:00 BST
  3. Contract starts
    1 Mar 2022
  4. Notice published
    1 Mar 2022, 12:15 GMT

Notice history

1 event · 2 releases on Find a Tender
  1. Status changed to complete
    1 Mar 2022, 12:15 GMT

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 27admitted to the panel · see the list ↓
Bids received 234 from SMEs · busiest of 5 lots
Contracts signed 20latest 7 Feb 2022

40 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofE

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 31 Aug 2022
    Status
    active
  • NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 31 Aug 2023
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaE

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 28 Feb 2023
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active
  • NHS Framework for the North of England, Branded Medicines -Tranche B

    Signed
    7 Feb 2022
    Value
    ceiling above
    Period
    … – 29 Feb 2024
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · CM/PHR/20/5600/01 - NHS Framework for the NOFE, Branded Medicines - Tranche B23bids · 23 electronic4——
2 · CM/PHR/20/5600/02 - NHS Framework for the NOFE, Branded Medicines-Annual Tranche20bids · 20 electronic2——
3 · CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®)-SofE1bids · 1 electronic———
4 · CM/PHR/20/5600/04-NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London1bids · 1 electronic———
5 · CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), MaE1bids · 1 electronic———

Contracting authority & participating public bodies

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authorityNHS & healthcareMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 2nd Floor, Rutland House, Runcorn, UK, WA7 2ESContact name, email Published organisation website ↗

Dispute resolution & review bodies

  • The High CourtReview body LondonContact email

Framework contractors & participating bidders

27 commercial parties on the notice
Show 17 more suppliers

Official documents & specifications (1)

Official links; attachments are not copied

Tender pack and attachments

  • Economic and financial selection criteriatenderEconomic and financial selection criteria